{"nct_id":"NCT00709618","title":"Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects","status":"TERMINATED","status_verified_date":"2014-06","start_date":"2008-06","start_date_type":null,"primary_completion_date":"2012-05","primary_completion_date_type":"ACTUAL","completion_date":"2012-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}